SCHEMBL1628950

SCHEMBL1628950

O=S(=O)(c1cc(-c2ccnn2-c2ccccc2Cl)c(O)cc1O)N1CCCCC1CO

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.45
OPRM1 P35372 1/20 0.42
OPRK1 P41145 1/20 0.42
ALOX5AP P20292 4/20 0.40
FEN1 P39748 3/20 0.40
ACLY P53396 1/20 0.37
NR3C2 P08235 1/20 0.36
COMT P21964 1/20 0.36
PLAU P00749 1/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
USP2 O75604 1/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ALDH1A1 P00352 1/20 0.35
MCOLN3 Q8TDD5 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1629183 0.86 OPRM1 (0.40) HSP90AA1OPRM1OPRK1ALOX5APFEN1
SCHEMBL1630408 0.83 HSP90AA1 (0.50) HSP90AA1NR3C2COMTHTTSMN1; SMN2
SCHEMBL1630170 0.82 HSP90AA1 (0.44) HSP90AA1ALOX5APFEN1ACLYNR3C2
SCHEMBL1629001 0.78 HSP90AA1 (0.49) HSP90AA1NR3C2KMT2AMEN1USP2
SCHEMBL1628793 0.78 HSP90AA1 (0.44) HSP90AA1ALOX5APFEN1ACLYNR3C2
SCHEMBL1631609 0.77 HSP90AA1 (0.55) HSP90AA1NR3C2KMT2AMEN1LMNA
SCHEMBL1629125 0.76 HSP90AA1 (0.53) HSP90AA1NR3C2KMT2ALMNASMN1; SMN2
SCHEMBL1628860 0.76 HSP90AA1 (0.45) HSP90AA1NR3C2KMT2AMEN1LMNA
SCHEMBL15049727 0.74 HSP90AA1 (0.53) HSP90AA1ACLYNR3C2LMNAHTT
SCHEMBL1629715 0.73 HSP90AA1 (0.52) HSP90AA1NR3C2KMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP claimed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US claimed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US claimed
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885OPRM1 3646/4885OPRK1 2566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.